Adrian is a seasoned IP lawyer who relishes immersing himself in his client’s technology, product roadmap and patent/IP strategy. He is regularly involved in the negotiation and drafting of technology licence agreements and other contracts with a heavy IP element, such as R&D collaborations, joint ventures, grant funding agreements and other commercial arrangements. He also advises on the EC and UK competition law aspects of these agreements, and issues relating to technical standardisation, essential IPR and patent pooling.

Adrian has a wealth of experience in handling the IP aspects of University spin-outs, IPOs and other major corporate transactions and disputes, including for FTSE 100 and Fortune 500 corporations. He is also a valued patent litigator, having recently advised on disputes involving pharmaceuticals, somatic cell therapy, semiconductor chip design, inkjet printing technology, digital compression algorithms, LCD flat-panel technology, telecoms and pharmaceuticals. He also frequently helps clients with disputes involving confidential information, database rights, trade marks, copyright and designs.

Adrian publishes and speaks regularly on a variety of intellectual property issues.

Show full CV Hide full CV

Latest news & insights

empty-chairs
Technology, media & communications

Intellectual property licences and insolvency

2 July 2020
IN-DEPTH ANALYSIS

by Adrian Toutoungi and Charlie Adams

Click here to find out more
Mobile Communications
Patents & innovation

IPCom v Lenovo – Court of Appeal of Paris

23 June 2020
IN-DEPTH ANALYSIS

by Adrian Toutoungi and Eelco Bergsma

Click here to find out more
scientist-with-vials
Life sciences & healthcare

Impact of COVID-19 on venture-backed biotech companies – Part 1: Operational issues

22 June 2020
IN-DEPTH ANALYSIS

by Adrian Toutoungi and Josef Fuss

Click here to find out more
black-robotic-arm
Synapse

COVID-19 postponement of MDR implementation date – how does this fit with Brexit?

26 May 2020
IN-DEPTH ANALYSIS

by Adrian Toutoungi

Click here to find out more

Related people

Meet me at

23 July

16:00 - 17:00

Webinar

Dissecting the Regeneron v Kymab mouse case – what it says and its impact on patents

More